THE Pharmaceutical Benefits Advisory Committee (PBAC) said it deferred six major submissions from consideration at its Nov 2017 meeting and now invites submissions on these from all stakeholders including interest groups, health professionals or patients - see pbs.gov.au for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Oct 17
